Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geoffrey L Rogers

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Frontiers in Microbiology|September 29, 2011
Innate Immune Responses to AAV VectorsGeoffrey L Rogers, Ashley T Martino, George V Aslanidi, et al.
Molecular Therapy. Methods & Clinical Development|October 27, 2021
Optimization of AAV6 transduction enhances site-specific genome editing of primary human lymphocytesGeoffrey L Rogers, Chun Huang, Robert D E Clark, et al.
Thrombosis and Haemostasis|September 30, 2016
Combination therapy for inhibitor reversal in haemophilia A using monoclonal anti-CD20 and rapamycinMoanaro Biswas, Geoffrey L Rogers, Alexandra Sherman, et al.
Journal of Virology|August 9, 2023
Comparison of SARS-CoV-2 entry inhibitors based on ACE2 receptor or engineered Spike-binding peptidesGeorge N Llewellyn, Hsu-Yu Chen, Geoffrey L Rogers, et al.
Journal of Innate Immunity|January 24, 2015
Unique Roles of TLR9- and MyD88-Dependent and -Independent Pathways in Adaptive Immune Responses to AAV-Mediated Gene TransferGeoffrey L Rogers, Masataka Suzuki, Irene Zolotukhin, et al.
Blood|April 3, 2015
Synergy between rapamycin and FLT3 ligand enhances plasmacytoid dendritic cell-dependent induction of CD4+CD25+FoxP3+ TregMoanaro Biswas, Debalina Sarkar, Sandeep R P Kumar, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 16, 2013
Differential type I interferon-dependent transgene silencing of helper-dependent adenoviral vs. adeno-associated viral vectors in vivoMasataka Suzuki, Terry K Bertin, Geoffrey L Rogers, et al.
Blood|February 21, 2015
Plant-based oral tolerance to hemophilia therapy employs a complex immune regulatory response including LAP+CD4+ T cellsXiaomei Wang, Jin Su, Alexandra Sherman, et al.
Biorxiv : the Preprint Server for Biology|July 10, 2023
Reprogramming human B cells with custom heavy chain antibodiesGeoffrey L Rogers, Chun Huang, Atishay Mathur, et al.
Research Square|July 28, 2023
Reprogramming human B cells with custom heavy chain antibodiesGeoffrey L Rogers, Chun Huang, Atishay Mathur, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Frontiers in Microbiology|September 29, 2011
Innate Immune Responses to AAV VectorsGeoffrey L Rogers, Ashley T Martino, George V Aslanidi, et al.
Molecular Therapy. Methods & Clinical Development|October 27, 2021
Optimization of AAV6 transduction enhances site-specific genome editing of primary human lymphocytesGeoffrey L Rogers, Chun Huang, Robert D E Clark, et al.
Thrombosis and Haemostasis|September 30, 2016
Combination therapy for inhibitor reversal in haemophilia A using monoclonal anti-CD20 and rapamycinMoanaro Biswas, Geoffrey L Rogers, Alexandra Sherman, et al.
Journal of Virology|August 9, 2023
Comparison of SARS-CoV-2 entry inhibitors based on ACE2 receptor or engineered Spike-binding peptidesGeorge N Llewellyn, Hsu-Yu Chen, Geoffrey L Rogers, et al.
Journal of Innate Immunity|January 24, 2015
Unique Roles of TLR9- and MyD88-Dependent and -Independent Pathways in Adaptive Immune Responses to AAV-Mediated Gene TransferGeoffrey L Rogers, Masataka Suzuki, Irene Zolotukhin, et al.
Blood|April 3, 2015
Synergy between rapamycin and FLT3 ligand enhances plasmacytoid dendritic cell-dependent induction of CD4+CD25+FoxP3+ TregMoanaro Biswas, Debalina Sarkar, Sandeep R P Kumar, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 16, 2013
Differential type I interferon-dependent transgene silencing of helper-dependent adenoviral vs. adeno-associated viral vectors in vivoMasataka Suzuki, Terry K Bertin, Geoffrey L Rogers, et al.
Blood|February 21, 2015
Plant-based oral tolerance to hemophilia therapy employs a complex immune regulatory response including LAP+CD4+ T cellsXiaomei Wang, Jin Su, Alexandra Sherman, et al.
Biorxiv : the Preprint Server for Biology|July 10, 2023
Reprogramming human B cells with custom heavy chain antibodiesGeoffrey L Rogers, Chun Huang, Atishay Mathur, et al.
Research Square|July 28, 2023
Reprogramming human B cells with custom heavy chain antibodiesGeoffrey L Rogers, Chun Huang, Atishay Mathur, et al.
Pageof 3